Notes: * In articles, when MP is added to drinkers, as a rule, the concentration of MP in drinkers is indicated as mg/l, when administered through a gastric tube - the amount of MP (mg) per animal

severe or persistent upper abdominal pain should prompt urgent medical assessment [10] [11] Dehydration and acute kidney injury (AKI): gastrointestinal fluid losses can lead to dehydration, which may precipitate AKI, particularly in those with pre-existing renal impairment or those taking nephrotoxic medicines Delayed gastric emptying: this may affect the absorption of orally administered medicines, including contraceptive pills and thyroid replacement therapy [11] Injection site reactions: redness, bruising, or discomfort at the subcutaneous injection site Heart rate changes: increases in resting heart rate have been noted with GLP-1 class agents [14] [15] Hypoglycaemia: particularly if used alongside insulin or sulphonylureas Potential pancreatitis risk: a class concern with GLP-1 receptor agonists
To date, 1-chloro-2,4-dinitrobenzene (CDNB), a ultraviolet chromogenic substrate, is the most prevalent probe for the assay of GST activity [4]
^ Protein S -glutathionylation: a regulatory device from bacteria to humans